Atlas Trials

Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities

Clinical trial NCT02406274 · COMPLETED

Trial details

NCT number
NCT02406274
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Abnormalities
Start date
2015-03-01
Primary completion
2024-06-27
Enrollment
249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.